| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 750970 | 3-[(E)-1-(3-1-[(4-fluorophenyl)sulfonyl]-4-piperidylimidazo[1,5-a]pyridin-1-yl)methylidene]-2-indolinone | 1.92684808686038e-005 | -0.61398317 |
| NSC 690116 | Null | 3.31921050119507e-005 | 0.58937202 |
| NSC 724780 | (1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15 | 3.31921050119509e-005 | 0.66748562 |
| NSC 711611 | Null | 4.20634348588214e-005 | 0.62450781 |
| NSC 123463 | Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) | 4.2063434858822e-005 | 0.43114173 |
| NSC 128571 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) | 4.2063434858822e-005 | 0.45412241 |
| NSC 169774 | Bromocriptine methanesulfonate | 4.2063434858822e-005 | 0.62936236 |
| NSC 635000 | Null | 4.2063434858822e-005 | 0.59233307 |
| NSC 640188 | Null | 4.2063434858822e-005 | 0.56805492 |
| NSC 749117 | 3-(2-Hydroxy-4-methoxyphenyl)-5-(4-methoxyphenyl)-1-(4-sulfamylphenyl)-2-pyrazoline | 4.93279880911877e-006 | 0.47603226 |